|
1.
Share Success: Letters From Readers
Letter
I: From Frank I.
Received
at CustomerService @ ezorbonline.com 11/29/17 at 11:09 AM
(Unedited)
Would like to know how many bottles I've purchased so far. I've been a customer for 2-3 months.
Also included in that email please send the confirmation for my latest purchase 11/27. I just want to know so I can see if I'm ready to start just taking the maintenance dose now.
When I started taking these I scheduled surgery for carpal tunnel on my finger. And now after taking the ezorb I don't have to have surgery. And my bone spurs are no longer painful.
Letter
II: From Virginia
Received
at Testimonial
Submit Form Tuesday, October 03, 2017 at 16:21:27
(Unedited)
Hi, my name is Virginia.
I started taking Ezorb calcium 2 years ago. I had been diagnosed with osteoporosis and the drug prescribed was not working for me.
However, after taking the calcium pills for 2 years, my GYN doc had my bone density tested in November 2016. The result was encouraging since the result was positive.
My bone density measurement increased. She advised me to continue taking the pills. Thanks for this wonderful product and I am religiously recommending to my family and friends.
Letter
III: From Marty
Received
at Testimonial
Submit Form Tuesday, October 03, 2017 at 11:21:37
(Unedited)
Hi, my name is Marty. I have been taking EZ Orb for four months now.
I have been told that I have osteoporosis and it was serious. The doctor wanted me to see an endocrinologist and begin taking shots. I declined because I do not trust medicine being injected into my body, not knowing the side effects.
I began researching online to find something else. When I read about EZ Orb, I decided to try it.
I used to have a problem with small bones in my feet cracking when I wore certain shoes. I don't have that problem anymore and I feel stronger. I tell everybody about EZ ORB and recommend that they try it! Thank you for making EZ ORB available!
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 95,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. If your testimonial is selected for publication, you will receive a gift to show
our appreciation of your effort.
2.
Research News: Physical Activity May Help Asthma Management
Researchers recommend addressing inactivity and sedentary time as a possible non-pharmacologic approach to managing severe asthma.
The recommendation is based on their findings that patients with severe asthma are "considerably" less active than the general population and that increasing activity levels and reducing sedentary time is associated with improved exercise capacity and asthma control, and lower levels of systemic inflammation.
The 61 patients with long-standing severe asthma (median of 27 years) achieved an average of 2455 fewer steps per day and 19.8 fewer minutes of moderate- to vigorous-intensity physical activity (MVPA) per day (p=0.0002, p lt.0.0001) than the 61 patients without asthma matched for age and sex.
Vanessa McDonald (National Health and Medical Research Council Centre of Excellence in Severe Asthma, Newcastle, New South Wales, Australia) and colleagues note that the patients with asthma achieved only 5362 daily steps, which is a little over half the recommended amount for adults.
Conversely, however, the patients with severe asthma did engage in an average 21.7 more minutes of light physical activity per day than controls (p=0.029). And there was no significant difference between the two groups in the time spent being sedentary.
The researchers report in The Journal of Allergy and Clinical Immunology: In Practice that steps, MVPA, and sedentary time were significantly associated with exercise capacity, as measured by the 6-minute walk distance (6MWD) test, explaining 35% (p=0.000), 30% (p=0.002), and 27% (p=0.006) of variance between individuals with and without asthma, respectively.
The relationship between daily steps and 6MWD was linear, with every additional 1000 steps walked per day increasing 6MWD by 16.9 m. For MVPA, there was a threshold effect, where individuals with severe asthma and a median 6MWD of 499 m or more were six times more likely to engage in recommended daily activity levels of at least 30 minutes.
McDonald and colleagues suggest that "this distance may be a suitable cutoff for people with severe asthma."
For every minute increase in sedentary time, 6MWD decreased by 0.47 m, equating to a 28.2 m reduction for every hour spent sedentary.
Indeed, even after adjusting for sedentary time, an increase of 1000 steps each day was associated with a 22 m increase in 6MWD.
"This suggests that the greatest benefit on exercise capacity is achieved by performing activity of light to moderate intensity distributed throughout the day, rather than more vigorous but sporadic activity," say McDonald et al.
Daily steps were also significantly associated with systemic inflammation, with every 1000 increase reducing high-sensitivity C-reactive protein levels by 13% and by 17% after adjusting for sedentary time (p=0.006 and 0.038, respectively). Systemic inflammation was not associated with sedentary time or MVPA, however.
Both activity variables and sedentary time were significantly associated with lung function, asthma control, and health status. The associations were weaker compared with those with exercise capacity and a greater increase in activity (gt. 4000 daily steps or gt. 25 minutes MVPA) was needed to have a clinically important difference, but the associations were "nonetheless statistically significant and biologically plausible," says the team.
They conclude: "Our results highlight a need to develop and test interventions in patients with severe asthma that aim to improve exercise capacity and systemic inflammation by increasing walking and decreasing sedentary time, and improve asthma control by increasing the volume of MVPA."
Original article appeared in 12-18-2017 | Asthma | News | Article.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
